CLINICAL-APPLICATION OF K-RAS ONCOGENE MUTATIONS IN PANCREATIC-CARCINOMA - DETECTION OF MICROMETASTASES

Citation
S. Nomoto et al., CLINICAL-APPLICATION OF K-RAS ONCOGENE MUTATIONS IN PANCREATIC-CARCINOMA - DETECTION OF MICROMETASTASES, Seminars in surgical oncology, 15(1), 1998, pp. 40-46
Citations number
22
Categorie Soggetti
Oncology,Surgery
ISSN journal
87560437
Volume
15
Issue
1
Year of publication
1998
Pages
40 - 46
Database
ISI
SICI code
8756-0437(1998)15:1<40:COKOMI>2.0.ZU;2-F
Abstract
Pancreatic adenocarcinomas are known to have a high incidence of K-ras gene mutation. We summarize our efforts to detect micrometastases thr ough a search for mutated K-ras oncogene in liver tissues, peritoneal washings, para-aortic lymph nodes, and perioperative peripheral blood. Two-stage polymerase chain reaction (PCR) and restriction fragment le ngth polymorphism (RFLP) analysis were used to detect K-ras oncogene m utations at codon 12. Our results suggest that PCR/RFLP analysis is po tentially highly sensitive for the detection of micrometastases in var ious tissues and might be of value in the diagnosis, treatment and fol low-up of metastases in other organs with pancreatic adenocarcinoma. ( C) 1998 Wiley-Liss, Inc.